Skip to main content
Premium Trial:

Request an Annual Quote

Nanosphere Q4, FY 2009 Revenues Rise

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nanosphere reported after the close of the market Wednesday that its fourth-quarter revenues rose to $828,000 from $313,000 year over year.

The Northbrook, Ill.-based molecular diagnostics firm reported a net loss of $9.1 million for the three-month period ended Dec. 31, versus $9.4 million for Q4 2008. It did not provide its loss per share for the quarter.

Nanosphere's R&D spending decreased 20 percent to $4.8 million from $6 million, while its SG&A spending increased 32 percent to $4.1 million from $3.1 million.

For full-year 2009, Nanosphere's revenues increased 57 percent to $2.2 million from $1.4 million. It said that $1 million of the 2009 revenues is attributable to an assay development contract with a major pharmaceutical firm.

"Having launched the Verigene SP with sample-to-result functionality and our first infectious disease assay, a respiratory virus panel, we are now serving hospital laboratory testing needs more broadly," Nanosphere President and CEO William Moffitt said in a statement.

The firm's net loss for the year declined to $33.9 million, or $1.46 per share, from $37 million, or $1.67 per share.

Its R&D spending for 2009 dropped to $18.6 million from $23.7 million, and its SG&A spending increased to $14.5 million from $13.6 million.

Nanosphere finished the year with $76.7 million in cash and cash equivalents.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.